CBD Oil vs NSAIDs for Dog Pain: What the Research Shows

Reviewed by ABSC Organics veterinary team | Updated March 2026

If your dog is in pain — whether from arthritis, surgery recovery, injury, or a chronic condition — your veterinarian has likely prescribed or recommended an NSAID (non-steroidal anti-inflammatory drug). These medications are the workhorse of canine pain management, and for good reason: they’re effective, widely available, and well-understood.

But NSAIDs come with risks. Serious risks. And the longer a dog takes them, the higher those risks become.

That reality has driven millions of pet parents to ask: is there a safer alternative? Could CBD oil manage my dog’s pain without the side effects?

This article provides a thorough, evidence-based comparison of CBD and NSAIDs for canine pain management. We’ll cover how each works, what the research shows about efficacy, the side effect profiles, long-term safety data, and when each option might be most appropriate. No hype — just a clear-eyed look at what the science supports.

How NSAIDs Work for Dog Pain

The Mechanism

NSAIDs work by inhibiting cyclooxygenase (COX) enzymes — specifically COX-1 and COX-2. These enzymes are responsible for producing prostaglandins, which are compounds that promote inflammation, pain, and fever.

By blocking COX enzymes, NSAIDs reduce prostaglandin production, which decreases inflammation and pain at the site of injury or disease. It’s a straightforward and effective mechanism.

Common Veterinary NSAIDs

The most commonly prescribed NSAIDs for dogs include:

• Carprofen (Rimadyl) — the most widely prescribed veterinary NSAID, commonly used for osteoarthritis and post-surgical pain
• Meloxicam (Metacam) — popular for arthritis management, available in liquid form
• Deracoxib (Deramaxx) — a COX-2 selective NSAID, sometimes preferred for its slightly more targeted action
• Firocoxib (Previcox) — another COX-2 selective option, commonly used for OA
• Grapiprant (Galliprant) — a newer option that works differently (blocks the EP4 receptor rather than COX enzymes), marketed as having fewer GI side effects

NSAID Efficacy

NSAIDs are effective pain relievers. That’s not in dispute. Studies consistently show that NSAIDs reduce pain scores and improve mobility in arthritic dogs. They work relatively quickly (often within hours of the first dose), and their effects are well-characterized after decades of veterinary use.

For acute pain — post-surgical, injury-related, or flare-ups of chronic conditions — NSAIDs are often the best immediate option. They provide reliable, fast-acting relief.

How CBD Works for Dog Pain

The Mechanism

CBD (cannabidiol) works through a fundamentally different mechanism than NSAIDs. Rather than blocking a single enzyme pathway, CBD interacts with multiple systems simultaneously:

• Endocannabinoid System (ECS): CBD modulates CB1 and CB2 receptor activity. CB2 receptors are particularly concentrated in immune cells and play a direct role in inflammatory response. By influencing CB2 receptor activity, CBD can reduce inflammation at its source.
• Serotonin Receptors (5-HT1A): CBD interacts with serotonin receptors, which may contribute to pain modulation and mood regulation — relevant for dogs whose chronic pain has led to behavioral changes like depression or anxiety.
• Vanilloid Receptors (TRPV1): These receptors are directly involved in pain perception. CBD’s interaction with TRPV1 may help modulate how pain signals are processed.
• Adenosine Receptors: CBD inhibits adenosine reuptake, which has anti-inflammatory effects.
• Immune Modulation: CBD appears to shift the balance of pro-inflammatory and anti-inflammatory cytokines, reducing the overall inflammatory burden without completely suppressing immune function.

This multi-target approach means CBD addresses pain through several pathways simultaneously — inflammation, pain signal processing, and the emotional/behavioral components of chronic pain.

CBD Efficacy: What the Research Shows

The most relevant clinical data comes from Colorado State University’s osteoarthritis trial, conducted using ABSC Organics CBD oil. This controlled study demonstrated significant improvements in mobility and comfort in arthritic dogs, with veterinary assessments and owner-reported outcomes both confirming meaningful benefit.

The CSU epilepsy study also indirectly supports CBD’s pain management potential: the 89% seizure reduction demonstrates that CBD has potent neurological activity at clinically relevant doses, confirming that it’s biologically active and measurably effective — not a placebo.

Beyond the CSU trials, a growing body of veterinary and human research supports CBD’s analgesic and anti-inflammatory properties. While the evidence base is smaller than what exists for NSAIDs (which have been studied for decades), the clinical data that does exist is compelling and consistent.

Side Effects: A Critical Comparison

This is where the comparison between CBD and NSAIDs becomes most consequential. Both are effective for pain — but their safety profiles are dramatically different.

NSAID Side Effects

NSAIDs carry well-documented risks, particularly with long-term use:

Gastrointestinal Damage

This is the most common category of NSAID side effects. COX-1 enzymes — which NSAIDs inhibit — aren’t just involved in inflammation. They also protect the stomach lining by maintaining the mucous barrier that shields gastric tissue from digestive acid.

When NSAIDs suppress COX-1 activity, that protective barrier thins. The result can range from mild stomach upset (decreased appetite, soft stool, vomiting) to serious gastrointestinal ulceration and bleeding. GI complications from NSAIDs are not rare: studies estimate that clinically significant GI events occur in 1-5% of dogs on long-term NSAID therapy, with subclinical damage occurring at higher rates.

Signs of GI damage include:

• Decreased appetite or refusal to eat
• Vomiting (sometimes with blood — a dark, coffee-ground appearance)
• Diarrhea (sometimes dark/tarry, indicating GI bleeding)
• Abdominal pain
• Weight loss

Liver Toxicity

NSAIDs are metabolized by the liver, and prolonged use can stress hepatic function. Some dogs develop elevated liver enzymes that progress to clinically significant hepatotoxicity. Carprofen (Rimadyl) has been associated with rare but serious idiosyncratic liver reactions — sudden, severe liver damage that can be fatal.

This is why veterinarians recommend regular bloodwork (typically every 6-12 months) for dogs on long-term NSAIDs. The monitoring isn’t optional — it’s a recognition that these drugs can cause organ damage that isn’t visible from the outside.

Kidney Damage

Prostaglandins play a role in maintaining kidney blood flow. By reducing prostaglandin production, NSAIDs can compromise renal perfusion, particularly in older dogs or dogs with pre-existing kidney issues. Long-term NSAID use is a recognized risk factor for chronic kidney disease progression.

Dogs who are dehydrated, under anesthesia, or taking other medications that affect kidney function are at particularly elevated risk.

Cardiovascular Risks

While less commonly discussed in veterinary medicine than in human medicine, some NSAIDs have been associated with increased cardiovascular risk. COX-2 selective NSAIDs, in particular, have come under scrutiny for potential effects on blood clotting and vascular function.

Drug Interactions

NSAIDs interact with numerous other medications, including corticosteroids (combining the two dramatically increases GI bleeding risk), other NSAIDs, certain antibiotics, ACE inhibitors, and anticoagulants. Managing these interactions requires careful veterinary oversight.

CBD Side Effects

The safety profile of CBD — specifically ABSC Organics CBD as studied at CSU — is markedly different:

What the CSU Studies Found

Across all three CSU clinical trials, the most consistently noted side effect was a mild, transient increase in alkaline phosphatase (ALP), a liver enzyme. Importantly:

• The ALP elevation was not associated with clinical signs of liver disease
• Other liver enzymes (ALT, AST) remained normal
• The elevation appeared to be a benign pharmacokinetic effect (related to how CBD is metabolized) rather than a sign of liver damage
• The long-term safety study confirmed that this effect did not progress to liver dysfunction over extended use

No Gastrointestinal Damage

Unlike NSAIDs, CBD does not inhibit the COX-1 enzymes that protect the stomach lining. There is no mechanism by which CBD would cause gastric ulceration or GI bleeding. Across the CSU studies, there were no reports of significant gastrointestinal adverse effects.

No Kidney Concerns

CBD does not affect prostaglandin-mediated kidney blood flow. Renal function parameters remained normal throughout the CSU safety study.

No Cardiovascular Concerns

No cardiovascular adverse effects were observed in any of the CSU studies.

Mild Sedation (Rare)

Some dogs — particularly at higher doses or when first starting CBD — may show mild drowsiness. This is typically transient, resolving within a few days as the body adjusts, and can be managed by starting at a lower dose and increasing gradually.

Side-by-Side Comparison Table

When NSAIDs Are the Better Choice

Despite their risks, there are situations where NSAIDs are the more appropriate option:

• Acute, severe pain: Post-surgical recovery, acute injuries, or severe flare-ups of chronic conditions where fast-acting relief is essential. NSAIDs’ rapid onset of action (hours vs. days for CBD) makes them better suited for acute pain management.
• Short-term use: When pain management is needed for days or a few weeks (not months or years), the risk-benefit calculation shifts in favor of NSAIDs since most serious side effects are associated with prolonged use.
• Under close veterinary monitoring: When your vet can closely monitor bloodwork and watch for early signs of adverse effects, short courses of NSAIDs are generally safe and highly effective.

When CBD May Be the Better Choice

• Long-term chronic pain management: For conditions like osteoarthritis that require daily pain management for months or years, CBD’s superior long-term safety profile is a significant advantage.
• Dogs who can’t tolerate NSAIDs: Some dogs develop GI problems, liver enzyme elevations, or other adverse effects on NSAIDs. CBD offers an alternative with a fundamentally different safety profile.
• Senior dogs with compromised organs: Older dogs with pre-existing kidney or liver issues may not be candidates for NSAID therapy. CBD, which doesn’t stress these organs in the same way, may be a safer option.
• Dogs on multiple medications: When drug interactions with NSAIDs are a concern, CBD may offer a simpler pharmacological picture.
• Multi-symptom management: If your dog has pain plus anxiety, or pain plus seizures, CBD may address multiple issues simultaneously — reducing the total number of medications needed.
• Pet parents who value organic, natural approaches: ABSC’s USDA Organic certification ensures a clean, chemical-free product for owners prioritizing natural wellness.

The Combined Approach: CBD + Reduced NSAID Dose

An increasingly common approach — and one worth discussing with your veterinarian — is combining CBD with a reduced NSAID dose. The logic is straightforward: if CBD provides a baseline of pain relief and anti-inflammatory activity, a lower dose of the NSAID may be sufficient to achieve the same comfort level, while significantly reducing the risk of NSAID-related side effects.

Several of the Golden Retriever owners who shared their experiences with ABSC reported exactly this approach. One owner described reducing her dog’s carprofen dose by half after introducing CBD, with her veterinarian noting improved bloodwork as a result of the lower NSAID exposure.

Important: Never reduce or change your dog’s NSAID dosage without veterinary guidance. Abrupt changes in pain medication can cause rebound pain and other complications. Your veterinarian can help you develop a safe tapering strategy if you want to explore adding CBD while reducing NSAIDs.

What About Galliprant (Grapiprant)?

Galliprant is sometimes presented as a “safer NSAID” because it works through a different mechanism (EP4 receptor antagonist rather than COX inhibition). It’s worth briefly addressing how it compares in this context.

Galliprant does appear to have a somewhat better GI safety profile than traditional COX-inhibiting NSAIDs. However:

• It can still cause vomiting, diarrhea, and decreased appetite
• Liver and kidney monitoring is still recommended
• It’s significantly more expensive than traditional NSAIDs
• Long-term safety data, while growing, is less extensive than for older NSAIDs
• It does not offer the additional benefits (anti-anxiety, anti-seizure) that CBD provides

Galliprant may be a good NSAID alternative for dogs who can’t tolerate traditional NSAIDs, but it doesn’t address the fundamental concern about long-term pharmaceutical pain management that drives many pet parents toward CBD.

The Cost Comparison

Financial reality matters. Here’s a realistic cost comparison for managing a 60-pound dog with chronic arthritis:

NSAIDs

• Carprofen (generic): approximately $30-50/month
• Galliprant: approximately $60-90/month
• Required bloodwork (every 6-12 months): $150-300 per panel
• Potential cost of treating NSAID side effects: variable, potentially thousands

ABSC Organics CBD

• 1200mg bottle ($119.99): lasts approximately 30-45 days for a 60-lb dog at standard dosing
• With 15% subscription discount: approximately $102/month
• No mandatory monitoring bloodwork (though we recommend baseline panels)
• No expected costs for treating side effects

CBD is more expensive on a monthly basis than generic carprofen, but comparable to Galliprant. When you factor in the cost of required monitoring bloodwork and the potential cost of treating NSAID complications, the total cost of ownership over years of chronic pain management may be similar — and CBD’s cost comes without the organ damage risk.

Questions to Ask Your Veterinarian

If you’re considering CBD as an alternative or complement to NSAIDs for your dog’s pain, here are productive questions to bring to your vet:

1. “Given my dog’s age and organ function, what are the long-term risks of continued NSAID use?”
2. “Are you familiar with the CSU clinical trials on CBD for canine osteoarthritis?”
3. “Would you be open to a trial period where we introduce CBD and monitor whether we can reduce the NSAID dose?”
4. “What bloodwork should we do before starting CBD, and what should we monitor?”
5. “Are there any interactions between CBD and my dog’s current medications that I should know about?”

The Bottom Line

NSAIDs and CBD both have legitimate roles in canine pain management. NSAIDs are faster-acting and have a deeper evidence base. CBD offers superior long-term safety, additional therapeutic benefits, and no risk of GI ulceration, liver toxicity, or kidney damage.

For dogs needing chronic, long-term pain management — particularly senior dogs, dogs with compromised organs, or dogs who don’t tolerate NSAIDs — CBD represents a meaningful alternative backed by real clinical data.

ABSC Organics is the only pet CBD brand with three clinical trials at Colorado State University, including a dedicated osteoarthritis study and a long-term safety study. When you’re choosing a product to manage your dog’s pain for months or years, that evidence matters.

Explore the full CBD for dog pain resource, or find the right product for your dog:

• 300mg CBD Oil — $49.99 (small dogs)
• 600mg CBD Oil — $59.99 (medium dogs)
• 1200mg CBD Oil — $119.99 (large dogs)
• 2400mg CBD Oil — $199.99 (extra-large dogs)

Subscribe and save 15% on every order. Your dog’s comfort shouldn’t have to come with organ damage risk.